As of 2024-07-27, the Relative Valuation of Veracyte Inc (VCYT) is (27.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.72 USD, the upside of Veracyte Inc based on Relative Valuation is -216.5%.
The range of the Relative Valuation is (27.47) - (27.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 30.1x - 31.2x | 30.6x |
| Fair Price | (27.47) - (27.82) | (27.62) |
| Upside | -215.8% - -217.3% | -216.5% |
| Date | P/E |
| 2024-07-26 | -26.60 |
| 2024-07-25 | -26.64 |
| 2024-07-24 | -26.26 |
| 2024-07-23 | -26.35 |
| 2024-07-22 | -26.32 |
| 2024-07-19 | -25.99 |
| 2024-07-18 | -26.83 |
| 2024-07-17 | -28.35 |
| 2024-07-16 | -28.66 |
| 2024-07-15 | -25.33 |
| 2024-07-12 | -25.51 |
| 2024-07-11 | -25.31 |
| 2024-07-10 | -24.12 |
| 2024-07-09 | -23.85 |
| 2024-07-08 | -24.33 |
| 2024-07-05 | -24.14 |
| 2024-07-03 | -24.08 |
| 2024-07-02 | -23.84 |
| 2024-07-01 | -23.92 |
| 2024-06-28 | -24.30 |
| 2024-06-27 | -24.66 |
| 2024-06-26 | -25.23 |
| 2024-06-25 | -25.49 |
| 2024-06-24 | -25.72 |
| 2024-06-21 | -25.28 |
| 2024-06-20 | -24.40 |
| 2024-06-18 | -24.01 |
| 2024-06-17 | -23.97 |
| 2024-06-14 | -23.51 |
| 2024-06-13 | -24.43 |
| 2024-06-12 | -24.75 |
| 2024-06-11 | -23.87 |
| 2024-06-10 | -23.41 |
| 2024-06-07 | -23.16 |
| 2024-06-06 | -24.01 |
| 2024-06-05 | -24.46 |
| 2024-06-04 | -23.87 |
| 2024-06-03 | -23.72 |
| 2024-05-31 | -23.27 |
| 2024-05-30 | -23.54 |
| 2024-05-29 | -23.31 |
| 2024-05-28 | -24.05 |
| 2024-05-24 | -23.32 |
| 2024-05-23 | -23.37 |
| 2024-05-22 | -24.24 |
| 2024-05-21 | -24.42 |
| 2024-05-20 | -25.01 |
| 2024-05-17 | -25.66 |
| 2024-05-16 | -26.24 |
| 2024-05-15 | -26.41 |